CD47 and acute myeloid leukemia: Therapies involving the blockage of the CD47/SIRPɑ axis also showed efficacy in xenograft models transplanted with patient‐derived AML stem cells.13 In conclusion, the binding of CD47 to SIRPα presents a negative signal to immune cells, especially macrophages, and promotes the survival of tumor cells.